Product Description: Citarinostat (ACY241) is a second generation potent, orally active and high-selective HDAC6 inhibitor with an IC50 of 2.6 nM (IC50s of 35 nM, 45 nM, 46 nM and 137 nM for HDAC1, HDAC2, HDAC3 and HDAC8, respectively). Citarinostat has anticancer effects[1].
Applications: Cancer-programmed cell death
Formula: C24H26ClN5O3
References: [1]Huang P, et al. Selective HDAC inhibition by ACY-241 enhances the activity of NSC 125973 in solid tumor models. Oncotarget. 2017 Jan 10;8(2):2694-2707.
CAS Number: 1316215-12-9
Molecular Weight: 467.95
Compound Purity: 99.30
Research Area: Cancer
Solubility: DMSO : ≥ 30 mg/mL
Target: HDAC